Zacks.com on MSN12d
Merck Halts Second PAH Drug Study Early on Strong Efficacy Results
Merck MRK has decided to stop the phase III HYPERION study early. The study evaluates MRK’s pulmonary arterial hypertension ...
Interesting Engineering28d
US nuclear engineers hit 100-test milestone, advancing Gen-IV reactor design
The laboratory is leading the charge in developing the next generation of nuclear reactors, known as Gen-IV reactors. These reactors promise to be safer, more efficient and produce less waste than ...